Bayer to challenge India cancer drug ruling

An assortment of pills Natco Pharma's version of Nexavar will be much cheaper for patients

Related Stories

German drug maker Bayer has said it will challenge India's decision to allow the production of a cheaper generic copy of a patented cancer drug.

Last year, India allowed Natco Pharma to produce Nexavar and, on Monday, the patent appeals office rejected Bayer's plea to overturn that ruling.

On Tuesday, Bayer said it "strongly" disagreed with the decision and would appeal in the high court of Mumbai.

Bayer sells the drug for 280,000 rupees ($5,118; £3,374) for a 120-tablet pack.

Natco says a 120-tablet pack of Nexavar will be available for 8,800 rupees ($176; £112).

"Bayer is committed to protecting its patents for Nexavar and will rigorously continue to defend our intellectual property rights within the Indian legal system," the company said in a statement quoted by the Associated Press.

Health groups have welcomed the decision, saying it would lead to more affordable versions of patented medicines.

"The decision means that the way has been paved for compulsory licenses to be issued on other drugs, now patented in India and priced out of affordable reach, to be produced by generic companies and sold at a fraction of the price,'' Leena Menghaney of the medical charity Medecins Sans Frontieres (MSF) said.

This is the first case in India of a company being granted a "compulsory license" to manufacture a patented drug. Under the rule, Natco must pay 7% in royalties to Bayer.

More on This Story

Related Stories

More India stories


Features & Analysis

  • Stained glass of man with swordFrance 1 England 0

    The most important battle you have probably never heard of

  • Golden retriever10 things

    Dogs get jealous, and nine more nuggets from the week's news

  • Pro-Israel demonstrators shout slogans while protesting in Berlin - 25 July 2014Holocaust guilt

    Gaza conflict leaves Germans confused over who to support

  • The emir of Kuwait Sheikh Sabah al-Ahmad al-Jaber al-SabahFreedoms fear

    Growing concern for rights as Kuwait revokes citizenships

Elsewhere on the BBC

  • CastleRoyal real estate

    No longer reserved for kings and queens, some find living in a castle simply divine


  • A robot which is due to compete in the 2014 RoboCupClick Watch

    Why robots from 45 countries are playing football in Brazil, plus other technology news

BBC © 2014 The BBC is not responsible for the content of external sites. Read more.

This page is best viewed in an up-to-date web browser with style sheets (CSS) enabled. While you will be able to view the content of this page in your current browser, you will not be able to get the full visual experience. Please consider upgrading your browser software or enabling style sheets (CSS) if you are able to do so.